Soluble CD127 potentiates IL‐7 activity in vivo in healthy mice
Abstract Introduction Soluble forms of cytokine receptors can be involved in the endogenous regulation of cytokine activity. Soluble interleukin 7 receptor α (sCD127) naturally binds IL‐7, therefore there is interest in its potential application as an immunotherapeutic agent to regulate IL‐7. With t...
Guardado en:
Autores principales: | , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Wiley
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c0fcfa2918b042dda1c5bf3eaa964d74 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:c0fcfa2918b042dda1c5bf3eaa964d74 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:c0fcfa2918b042dda1c5bf3eaa964d742021-11-12T19:57:15ZSoluble CD127 potentiates IL‐7 activity in vivo in healthy mice2050-452710.1002/iid3.530https://doaj.org/article/c0fcfa2918b042dda1c5bf3eaa964d742021-12-01T00:00:00Zhttps://doi.org/10.1002/iid3.530https://doaj.org/toc/2050-4527Abstract Introduction Soluble forms of cytokine receptors can be involved in the endogenous regulation of cytokine activity. Soluble interleukin 7 receptor α (sCD127) naturally binds IL‐7, therefore there is interest in its potential application as an immunotherapeutic agent to regulate IL‐7. With the hypothesis that sCD127 enhances IL‐7 activity, thus promoting T‐cell proliferation in vivo, we sought to assess the effect of sCD127, IL‐7 or IL‐7 + sCD127 treatment on CD4+ and CD8+ T‐cells in the blood and spleen of mice. Methods Peripheral blood mononuclear cells and splenocytes were prepared, and analyzed for T‐cell number, phenotype and proliferation (Ki67+) by flow cytometry. Results IL‐7 treatment induced T‐cell proliferation, increased T‐cell number, and triggered T‐cell differentiation each of which was enhanced with the addition of sCD127. IL‐7 + sCD127 treatment significantly increased spleen weight over that seen with IL‐7 treatment alone. More pronounced proliferation and a greater increase in cell number was observed in CD8+ T‐cells relative to the effect on CD4+ T‐cells. Conclusions These findings suggest that the addition of sCD127 enhances IL‐7‐mediated T‐cell proliferation and suggests a potential therapeutic use for sCD127.Nawaf A. AloufiAlaa K. AliStephanie C. Burke SchinkelBengisu MolyerPriscila O. BarrosJoanne E. McBaneSeung‐Hwan LeeJonathan B. AngelWileyarticleCD4+ T‐cellCD8+ T‐cellinterleukin‐7 (IL‐7)soluble IL‐7Rα (sCD127)T‐cell proliferationImmunologic diseases. AllergyRC581-607ENImmunity, Inflammation and Disease, Vol 9, Iss 4, Pp 1798-1808 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
CD4+ T‐cell CD8+ T‐cell interleukin‐7 (IL‐7) soluble IL‐7Rα (sCD127) T‐cell proliferation Immunologic diseases. Allergy RC581-607 |
spellingShingle |
CD4+ T‐cell CD8+ T‐cell interleukin‐7 (IL‐7) soluble IL‐7Rα (sCD127) T‐cell proliferation Immunologic diseases. Allergy RC581-607 Nawaf A. Aloufi Alaa K. Ali Stephanie C. Burke Schinkel Bengisu Molyer Priscila O. Barros Joanne E. McBane Seung‐Hwan Lee Jonathan B. Angel Soluble CD127 potentiates IL‐7 activity in vivo in healthy mice |
description |
Abstract Introduction Soluble forms of cytokine receptors can be involved in the endogenous regulation of cytokine activity. Soluble interleukin 7 receptor α (sCD127) naturally binds IL‐7, therefore there is interest in its potential application as an immunotherapeutic agent to regulate IL‐7. With the hypothesis that sCD127 enhances IL‐7 activity, thus promoting T‐cell proliferation in vivo, we sought to assess the effect of sCD127, IL‐7 or IL‐7 + sCD127 treatment on CD4+ and CD8+ T‐cells in the blood and spleen of mice. Methods Peripheral blood mononuclear cells and splenocytes were prepared, and analyzed for T‐cell number, phenotype and proliferation (Ki67+) by flow cytometry. Results IL‐7 treatment induced T‐cell proliferation, increased T‐cell number, and triggered T‐cell differentiation each of which was enhanced with the addition of sCD127. IL‐7 + sCD127 treatment significantly increased spleen weight over that seen with IL‐7 treatment alone. More pronounced proliferation and a greater increase in cell number was observed in CD8+ T‐cells relative to the effect on CD4+ T‐cells. Conclusions These findings suggest that the addition of sCD127 enhances IL‐7‐mediated T‐cell proliferation and suggests a potential therapeutic use for sCD127. |
format |
article |
author |
Nawaf A. Aloufi Alaa K. Ali Stephanie C. Burke Schinkel Bengisu Molyer Priscila O. Barros Joanne E. McBane Seung‐Hwan Lee Jonathan B. Angel |
author_facet |
Nawaf A. Aloufi Alaa K. Ali Stephanie C. Burke Schinkel Bengisu Molyer Priscila O. Barros Joanne E. McBane Seung‐Hwan Lee Jonathan B. Angel |
author_sort |
Nawaf A. Aloufi |
title |
Soluble CD127 potentiates IL‐7 activity in vivo in healthy mice |
title_short |
Soluble CD127 potentiates IL‐7 activity in vivo in healthy mice |
title_full |
Soluble CD127 potentiates IL‐7 activity in vivo in healthy mice |
title_fullStr |
Soluble CD127 potentiates IL‐7 activity in vivo in healthy mice |
title_full_unstemmed |
Soluble CD127 potentiates IL‐7 activity in vivo in healthy mice |
title_sort |
soluble cd127 potentiates il‐7 activity in vivo in healthy mice |
publisher |
Wiley |
publishDate |
2021 |
url |
https://doaj.org/article/c0fcfa2918b042dda1c5bf3eaa964d74 |
work_keys_str_mv |
AT nawafaaloufi solublecd127potentiatesil7activityinvivoinhealthymice AT alaakali solublecd127potentiatesil7activityinvivoinhealthymice AT stephaniecburkeschinkel solublecd127potentiatesil7activityinvivoinhealthymice AT bengisumolyer solublecd127potentiatesil7activityinvivoinhealthymice AT priscilaobarros solublecd127potentiatesil7activityinvivoinhealthymice AT joanneemcbane solublecd127potentiatesil7activityinvivoinhealthymice AT seunghwanlee solublecd127potentiatesil7activityinvivoinhealthymice AT jonathanbangel solublecd127potentiatesil7activityinvivoinhealthymice |
_version_ |
1718430340325834752 |